American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
PetVivo Holdings, Inc.
$0.80
+9.42%
OTC: PETV · 15-min delayed
$1.1MRevenue · FY2025
-$8.4MNet income
PETVOTC
About PetVivo Holdings, Inc.
PETVIVO HOLDINGS INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2025
- $1.1M
- Net income
- -$8.4M
- Total assets
- $9.3M
- Gross margin
- 76.3%
- Operating margin
- -1096.4%
- Net margin
- -1130.9%
Source: SEC EDGAR · updated Jun 8, 2026
Multi-year
Revenue & profit trend
FY2022
FY2023
FY2024
Revenue Net income
FY 2024
Financial statements
Income statement
- Revenue
- $968.7K
- Cost of revenue
- $229.2K
- Gross profit
- $739.5K
- Operating expenses
- $11.4M
- Operating income
- -$10.6M
- Net income
- -$11.0M
- EPS (basic)
- $-0.78
- EPS (diluted)
- $-0.78
Balance sheet
- Total assets
- $3.1M
- Current assets
- $1.0M
- Total liabilities
- $2.4M
- Current liabilities
- $1.4M
- Shareholders’ equity
- $686.0K
Cash flow
- Operating cash flow
- -$7.4M
- Investing cash flow
- -$309.1K
- Financing cash flow
- $7.3M
- Net cash flow
- -$387.9K
Statements via Polygon.io (SEC filings)
- EPS (diluted)
- $-0.78
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Reported a net loss of $8.4M in FY2025.
- Revenue grew 738% from FY2022 to FY2024.
- Gross margin of 76.3%, net margin -1130.9%.
- Trading 47% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PetVivo Holdings, Inc..
Write a review
Newsroom
News about PetVivo Holdings, Inc.
PetVivo Holdings, Inc. to Host Virtual Investor Event
PetVivo Sets Fiscal Second Quarter 2026 Conference Call for Friday, November 14, 2025 at 5:00 p.m. ET
PetVivo Animal Health Expands Veterinary Education with New RACE-Approved CE Courses on Osteoarthritis and Regenerative Therapies
PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH NUPSALA LIMITED
OTC Markets Group Announces Second Quarter 2025 Earnings Conference Call and Webcast
OTC Markets Group Welcomes PetVivo Holdings Inc. to OTCQX
News & sentiment via Polygon.io
Explore
Browse all →
